Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Khaled M. Abouelkhair"'
Publikováno v:
Polish Journal of Radiology. 84:570-580
Purpose To assess the role of 1H-magnetic resonance spectroscopy (1H-MRS) in the confirmation of pathological complete response after neoadjuvant chemotherapy in breast cancer. Material and methods Forty-seven cases (53.72 ± 8.53 years) were evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68e9193640aedb0416540cd657dbe5d0
https://doi.org/10.5114/pjr.2019.92282
https://doi.org/10.5114/pjr.2019.92282
Publikováno v:
Polish Journal of Radiology
Purpose To assess the role of 1H-magnetic resonance spectroscopy (1H-MRS) in the confirmation of pathological complete response after neoadjuvant chemotherapy in breast cancer. Material and methods Forty-seven cases (53.72 ± 8.53 years) were evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5e6c249e07fe7c2f915c9494d1f189d8
https://pubmed.ncbi.nlm.nih.gov/32082456
https://pubmed.ncbi.nlm.nih.gov/32082456
Autor:
Osama A. Elmasri, Ezzeldin M. Ibrahim, Mubarak Al-Mansour, Khaled M. Abouelkhair, Meteb Al-Foheidi, Ghieth A. Kazkaz, Ali M. Bayer, Turki M Al-Fayea
Publikováno v:
Lung. 191:117-134
Patients treated for Hodgkin’s lymphoma (HL) have a higher risk of developing second lung cancer (SLC) compared with the general population. The aim of this meta-analysis was to quantify such risk and to analyze contributing risk factors in HL surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fb1ddfec5b032e92b793c0a5b2ad67c
https://doi.org/10.1007/s00408-012-9418-4
https://doi.org/10.1007/s00408-012-9418-4
Autor:
Najeeb C. Chaudry, Osama A. Al-Masri, Ezzeldin M. Ibrahim, Khaled M. Abouelkhair, Ghieth A. Kazkaz
Publikováno v:
Lung. 189:193-198
Randomized controlled trails (RCTs) where cetuximab added to first-line platinum-based chemotherapy for patients with advanced/metastatic non-small-cell lung cancer (NSCLC) have yielded conflicting results. This meta-analysis intended to evaluate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c47f5f38aed9ce20164b8e142e9074a
https://doi.org/10.1007/s00408-011-9286-3
https://doi.org/10.1007/s00408-011-9286-3
Autor:
Osama A. Elmasri, Meteb Al-Foheidi, Ezzeldin M. Ibrahim, Ghieth A. Kazkaz, Khaled M. Abouelkhair
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 197 (2012)
BMC Cancer
BMC Cancer
Background Women treated for Hodgkin’s lymphoma (HL) have an elevated risk of developing second breast cancer (SBC) compared with the general population. We planned this meta-analysis to quantify the long-term risk of SBC and analyze the contributi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5891685cb9009496bdee9b2974bedc76
http://www.biomedcentral.com/1471-2407/12/197
http://www.biomedcentral.com/1471-2407/12/197
Publikováno v:
Medical oncology (Northwood, London, England). 28
Panitumumab is a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody that has a favorable effect on patients with metastatic colorectal cancer (mCRC) harboring wild-type (WT) KRAS gene. This meta-analysis was planned to quant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd438acad1a3c15ad2a3f3a699043020
https://pubmed.ncbi.nlm.nih.gov/21221853
https://pubmed.ncbi.nlm.nih.gov/21221853
Autor:
Michela Del Prete, Rodolfo Montironi, Luca Faloppi, Stefano Cascinu, Cristian Loretelli, Khaled M. Abouelkhair, Maristella Bianconi, Riccardo Giampieri, Alessandra Mandolesi, Mario Scartozzi, Marina Scarpelli, Alessandro Bittoni, Ezzeldin M. Ibrahim
Publikováno v:
Journal of Clinical Oncology. 33:596-596
596 Background: Many markers for a “beyond-RAS” selection of CRC patients receiving cetuximab have been suggested, but none entered clinical practice mainly because prospective validation was lacking. Aim of our study was to evaluate if a molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec3fc886a8d82a3628527c3122328050
https://doi.org/10.1200/jco.2015.33.3_suppl.596
https://doi.org/10.1200/jco.2015.33.3_suppl.596
Autor:
Luca Cecchini, Ezzeldin M. Ibrahim, Michela Del Prete, Alessandra Mandolesi, Khaled M. Abouelkhair, Maristella Bianconi, Luca Faloppi, Cristian Loretelli, Alessandro Bittoni, Riccardo Giampieri, Stefano Cascinu, Mario Scartozzi, Italo Bearzi
Publikováno v:
Journal of Clinical Oncology. 31:3591-3591
3591 Background: Translational research identified numerous putative markers for a “beyond-k-RAS” selection of colorectal cancer patients receiving cetuximab, but none of these entered clinical practice mainly because prospective validation is la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98389ceef8d0922250a8019fe7433f52
https://doi.org/10.1200/jco.2013.31.15_suppl.3591
https://doi.org/10.1200/jco.2013.31.15_suppl.3591